Get the Stockscreener App
1.13
2.73%
0.03
Pre-market:
1.13
Mangoceuticals Inc stock is traded at $1.13, with a volume of 124.83K.
It is up +2.73% in the last 24 hours and down -34.30% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$1.10
Open:
$1.1
24h Volume:
124.83K
Relative Volume:
0.09
Market Cap:
$15.71M
Revenue:
$516.00K
Net Income/Loss:
$-14.20M
P/E Ratio:
-0.3543
EPS:
-3.1891
Net Cash Flow:
$-5.83M
1W Performance:
-3.42%
1M Performance:
-34.30%
6M Performance:
-43.64%
1Y Performance:
-55.69%
1-Day Range:
$1.07
$1.15
1-Week Range:
$1.06
$1.22
52-Week Range:
$0.98
$6.15
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.13 | 15.30M | 516.00K | -14.20M | -5.83M | -3.1891 |
|
VEEV
Veeva Systems Inc
|
229.49 | 37.67B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
73.86 | 13.36B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.39 | 8.18B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
44.13 | 8.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
35.90 | 6.35B | 11.99B | 24.18M | 234.31M | 0.2956 |
Mangoceuticals Inc Stock (MGRX) Latest News
Eugene Johnston Sells 5,000 Shares of Mangoceuticals Inc (MGRX) - GuruFocus
Mangoceuticals Secures $75,000 Loan from CEO Trust - TipRanks
Mangoceuticals CFO Cashes Out: What This Means for Investors - TipRanks
CFO Johnston sells Mangoceuticals (MGRX) shares for $11,279 By Investing.com - Investing.com Australia
CFO Johnston sells Mangoceuticals (MGRX) shares for $11,279 - Investing.com
Insider Buy: Is Mangoceuticals Inc stock dividend yield sustainableJuly 2025 Opening Moves & Smart Investment Allocation Tips - moha.gov.vn
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Mangoceuticals Inc. stock maintain dividend yieldRecession Risk & Verified Momentum Watchlists - Newser
How Mangoceuticals Inc. stock compares to growth peersTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
There is no way Mangoceuticals Inc (MGRX) can keep these numbers up - Setenews
How Mangoceuticals Inc. stock performs in rising dollar environment2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs - MSN
How geopolitical tensions affect Mangoceuticals Inc. stock2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Setup Watch: Can POET stock reach 100 price targetJuly 2025 PostEarnings & Community Driven Trade Alerts - BỘ NỘI VỤ
Analysts Spot Bullish Divergence in Satchmo Holdings LimitedRelative Strength Index (RSI) & Affordable Investment Portfolio - earlytimes.in
What analysts say about Mangoceuticals Inc stockCandlestick Trading Patterns & Demo Trading Rooms Open Daily - earlytimes.in
Is Mangoceuticals Inc (MGRX) positioned for future growth? - Setenews
Mangoceuticals Director Cashes In on Major Stock Sale! - TipRanks
Mangoceuticals (NASDAQ:MGRX) Downgraded by Wall Street Zen to Sell - Defense World
Will Mangoceuticals Inc. stock benefit from commodity pricesPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Is Mangoceuticals Inc. stock safe for conservative investors2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
Why Mangoceuticals Inc. stock is favored by pension fundsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Can Mangoceuticals Inc. stock reach $100 price targetWeekly Profit Report & Community Verified Trade Signals - newser.com
Evaluating Mangoceuticals Inc. with trendline analysisJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Why Mangoceuticals Inc. is moving todayJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Is Mangoceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Verified Technical Trade Signals - newser.com
Dir Hamilton Files To Sell 125,000 Of Mangoceuticals Inc [MGRX] - TradingView
How Mangoceuticals Inc. stock performs in weak economyMarket Activity Recap & Weekly Momentum Picks - newser.com
Will Mangoceuticals Inc. benefit from macro trendsStock Surge & Community Consensus Stock Picks - newser.com
Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim - MSN
Are Direct-to-Consumer Channels Reinforcing Eli Lilly’s (LLY) Competitive Edge in the Obesity Market? - simplywall.st
It is Poised to be a Bull Market for Mangoceuticals Inc (MGRX) - Setenews
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Novo Nordisk, Eli Lilly deny partnership with Mangoceuticals on weight-loss drugs - MSN
Can technical indicators confirm Mangoceuticals Inc.’s reversal2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
5.65%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):